ESR1 and cancer: Yadav et al.18, out from a series of 10.873 patients derived from the National Cancer DataBase, showed a rate of ER positivity of approximately 89%, and Wang et al.17 registered ER positivity rates of 83.9% on 1.816.733 patients out from the same series.